Clinical trial / 2021
Garlic tablet supplementation significantly reduced endometriosis-related pain compared to placebo over three months.
In a triple-blind trial, 60 women with endometriosis were randomly assigned to receive usual care plus either 400 mg garlic tablets or identical placebo tablets for three months. Pain was measured before intervention and at one-, two-, and three-month follow-ups using a four-part VAS. The overall severity of pain decreased from 6.51 ± 0.86 to 1.83 ± 1.25 in the garlic group (p < 0.05), but increased from 6.41 ± 1.12 to 6.65 ± 1.37 in the control group (p = 0.02). Repeated measures ANOVA demonstrated a significant difference in pain score changes between the groups (p < 0.001, np2 = 0.572).
- Study type
- Randomized placebo-controlled triple-blind clinical trial
- Who was studied
- 60 women with endometriosis
- What was measured
- Severity of endometriosis-related pain measured by Visual Analogue Scale (VAS)
THE PAPER
The Effect of Garlic Tablets on the Endometriosis-Related Pains: A Randomized Placebo-Controlled Clinical Trial.
Amirsalari S, Behboodi Moghadam Z, Taghizadeh Z, Jafar Abadi MN, Sabaghzadeh Irani P, Goodarzi S, Ranjbar H. Evid Based Complement Alternat Med, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.